Effects of Coffee Consumption on Glucose Tolerance, Serum Glucose and Insulin Levels - A Cross-sectional Analysis

Abstract

Objective: Coffee has several metabolic effects that could reduce the risk of type 2 diabetes. Our objective was to examine the effects of coffee consumption on glucose tolerance, glucose and insulin levels. Research design and methods: A subsample of subjects aged 45 to 64 years in 1987 and in 1992 from the population-based FINRISK study (12 287 individuals) was invited to receive the standard oral glucose tolerance test at baseline. Plasma samples were taken after an overnight fast, and a two-hour oral glucose tolerance test was administered. Fasting and two-hour plasma glucose and insulin were measured in 2434 subjects with data on coffee use and potential confounders. Results: After adjustment for potential confounding factors (age, body mass index, systolic blood pressure, occupational, commuting and leisure time physical activity, alcohol and tea drinking, smoking), coffee consumption was significantly and inversely associated with fasting glucose, two-hour plasma glucose, and fasting insulin in both men and women. Coffee consumption was significantly and inversely associated with impaired fasting glucose, impaired glucose regulation, and hyperinsulinemia among both men and women and with isolated impaired glucose tolerance among women. Conclusions: In this cross-sectional analysis, coffee showed positive effects on several glycemia markers.

Key words

Hypoglycemia - hyperinsulinemia - clorogenic acid - caffeine - glucose regulation

References

• 1 Clifford M N. Chlorogenic acid and other cinnamates-nature, occurrence and dietary burden.  J Sci Food Agric. 1999;  79 362-372
• 2 Clifford M N. Chlorogenic acid and other cinnamates-nature, occurrence, dietary burden, absorption and metabolism.  J Sci Food Agric. 2000;  80 1033-1043
• 3 Nauck M A, Heimesaat M M, Orskov C, Holst J J, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7 - 36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.  J Clin Invest. 1993;  91 301-307
• 4 Meier J J, Hucking K, Holst J J, Deacon C F, Schmiegel W H, Nauck M A. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.  Diabetes. 2001;  50 2497-2504
• 5 Tuomilehto J, Tuomilehto-Wolf E, Virtala E, LaPorte R. Coffee consumption as trigger for insulin dependent diabetes mellitus in childhood.  BMJ. 1990;  300 642-643
• 6 Barbagallo M, Dominguez L J, Galioto A. et al . Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X.  Mol Aspects Med. 2003;  24 39-52
• 7 Paolisso G, Scheen A, D’Onofrio F, Lefebvre P. Magnesium and glucose homeostasis.  Diabetologia. 1990;  33 511-514
• 8 Paolisso G, Ravussin E. Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians.  J Clin Endocrinol Metab. 1995;  80 1382-1385
• 9 Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium.  Am J Hypertens. 1997;  10 346-355
• 10 Van Dam R M, Feskens E J. Coffee consumption and risk of type 2 diabetes mellitus.  Lancet. 2002;  360 1477-1478
• 11 Salazar-Martinez E, Willett W C, Ascherio A, Leitzmann M, Manson J E, Stampfer M J, Hu F B. Coffee consumption and risk of Type 2 diabetes in men and women.  Ann Intern Med. 2004;  140 1-8
• 12 Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow up study.  J Intern Med. 2004;  255 89-95
• 13 Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women.  JAMA. 2004;  291 1213-1219
• 14 Carlsson S, Hammar N, Grill V, Kaprio J. Coffee consumption and risk of type 2 diabetes in Finnish twins.  Int J Epidemiol. 2004;  3 616-617
• 15 Van Dam R M, Hu F B. Coffee consumption and risk of type 2 diabetes: a systematic review.  JAMA. 2005;  294 97-104
• 16 Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972 - 1997.  Int J Epidemiol. 2000;  29 49-56
• 17 Hu G, Lindström J, Valle T T, Eriksson J G, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.  Arch Intern Med. 2004;  164 892-896
• 18 Yliharsila H, Lindström J, Eriksson J G, Jousilahti P, Valle T T, Sundvall J, Tuomilehto J. Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland.  Diabet Med. 2005;  22 88-91
• 19 WHO MONICA Project Principal Investigators . The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators.  J Clin Epidemiol. 1988;  41 105-114
• 20 Pajak A, Kuulasmaa K, Tuomilehto J, Ruokokoski E. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project.  World Health Stat Q. 1988;  41 115-140
• 21 Tuomilehto J, Korhonen H J, Kartovaara L, Salomaa V, Stengård J H, Pitkänen M, Aro A, Javela K, Uusitupa M, Pitkäniemi J. Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland.  Int J Epidemiol. 1991;  20 1010-1017
• 22 Hu G, Qiao Q, Silventoinen K, Eriksson J G, Jousilahti P, Lindström J, Valle T T, Nissinen A, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women.  Diabetologia. 2003;  46 322-329
• 23 Barengo N C, Hu G, Lakka T A, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland.  Eur Heart J. 2004;  25 2204-2211
• 24 Hu G, Barengo N C, Tuomilehto J, Lakka T A, Nissinen A, Jousilahti P. Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in Finland.  Hypertension. 2004;  43 25-30
• 25 Hu G, Eriksson J, Barengo N C, Lakka T A, Valle T T, Nissinen A, Jousilahti P, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes.  Circulation. 2004;  110 666-673
• 26 Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women.  Eur Heart J. 2004;  25 2212-2219
• 27 Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. Cambridge, MA; Harvard University Press 1980
• 28 WHO Consultation .Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva; World Health Organisation 1999
• 29 Van Dam R M, Dekker J M, Nijpels G, Stehouwer C DA, Bouter L M, Heine R J. Coffee consumption and incidence of impaired fasting glucose, impaired glucose, and type 2 diabetes: the Hoorn Study.  Diabetologia. 2004;  47 2152-2159
• 30 Yamaji T, Mizoue T, Tabata S, Ogava S, Yamaguchi K, Shimizu E, Mineshita M, Kono S. Coffee consumption and glucose tolerance status in middle-aged Japanese men.  Diabetologia. 2004;  47 2145-2151
• 31 Agardh E E, Carlsson S, Ahlbom A, Efendic S, Grill V, Hammar N, Hilding A, Ostenson C G. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women.  J Intern Med. 2004;  255 645-652
• 32 Frayn K N. Metabolic regulation, a human perspective. In: Snell K (ed) Frontiers in metabolism. London; Portland Press 1996: 103-111
• 33 Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K. Alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 2. Alpha-Glucosidase inhibition by isolated acylated anthocyanins.  J Agric Food Chem. 2001;  49 1952-1956
• 34 Kobayashi Y, Suzuki M, Satsu H. et al . Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism.  J Agric Food Chem. 2000;  48 5618-5623
• 35 Nauck M A, Heimesaat M M, Orskov C, Holst J J, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7 - 36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.  J Clin Invest. 1993;  91 301-307
• 36 Meier J J, Hucking K, Holst J J, Deacon C F, Schmiegel W H, Nauck M A. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.  Diabetes. 2001;  50 2497-2504
• 37 Newgard C B, Foster D W, McGarry J D. Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding.  Diabetes. 1984;  33 192-195
• 38 Youn J H, Youn M S, Bergman R N. Synergism of glucose and fructose in net glycogen synthesis in perfused rat livers.  J Biol Chem. 1986;  261 15 960-15 969
• 39 Arion W J, Canfield W K, Ramos F C. et al . Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase.  Arch Biochem Biophys. 1997;  339 315-322
• 40 Andrade-Cetto A, Wiedenfeld H. Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats.  J Ethnopharmacol. 2001;  78 145-149
• 41 Keijzers G B, De Galan B E, Tack C J, Smiths P. Caffeine can decrease insulin sesitivity in humans.  Diabetes Care. 2002;  25 364-369
• 42 Denaro C P, Brown C R, Jacob P, Benowitz N L. Effects of caffeine with repeated dosing.  Eur J Clin Pharmacol. 1991;  40 273-278
• 43 Arnlov J, Vessby B, Riserus U. Coffee consumption and insulin sensitivity.  JAMA. 2004;  291 1199-1201
• 44 Yeni-Komshian H, Carantoni M, Abbasi F, Reaven G M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.  Diabetes Care. 2002;  23 171-175
• 45 Laakso M. How good is insulin level for insulin resistance?.  Am J Epidemiol. 1992;  137 959-965
• 46 Ferrannini E, Mari A. How to measure insulin sensitivity.  J Hypertens. 1998;  16 895-906
• 47 Haffner S M, Valdez R A, Hazuda H P, Mitchell B D, Moralles P A, Stern M P. Prospective analaysis of the insulin-resistance syndrom (syndrom X).  Diabetes. 1992;  41 715-722
• 48 Zavaroni I, Bonora E, Pagliara M. et al . Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.  N Eng J Med. 1989;  320 702-706
• 49 Despres J P, Lamarch B, Maurige P. et al . Hyperinsulinemia as an independent risk factor for ischemic heart disease.  N Eng J Med. 1996;  334 952-957
• 50 Fontbonne A, Charles M A, Thibult N. et al . Hyperinsulinemia as a predictor of coronary heart disease mortality in healthy population: the Paris Prospective Study, 15-year follow-up.  Diabetologia. 1991;  34 356-361
• 51 Reunanen A, Heliovaara M, Aho K. Coffee consumption and risk of type 2 diabetes mellitus.  Lancet. 2003;  361 702-703
• 52 Saremi A, Tulloch-Reid M, Knowler W C. Coffee consumption and the incidence of type 2 diabetes.  Diabetes Care. 2003;  7 2211-2212